STIFEL FINANCIAL CORP - AVALO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$15,000
-16.7%
30,000
+20.0%
0.00%
Q1 2022$18,000
-30.8%
25,000
+66.7%
0.00%
Q4 2021$26,000
+18.2%
15,000
+50.0%
0.00%
Q3 2021$22,00010,0000.00%
Other shareholders
AVALO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 47,576,000$34,478,0000.67%
Opaleye Management Inc. 1,454,400$1,054,0000.33%
Nantahala Capital Management 6,849,547$4,804,0000.21%
Integral Health Asset Management, LLC 700,000$507,0000.13%
Ikarian Capital, LLC 764,271$554,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 1,198,757$869,0000.02%
Point72 Asset Management, L.P. 6,008,850$4,355,0000.02%
Gyon Technologies Capital Management, LP 18,242$13,0000.01%
LEO BROKERAGE, LLC 62,629$45,0000.01%
Minot Wealth Management LLC 34,645$25,0000.01%
View complete list of AVALO THERAPEUTICS INC shareholders